As of close of business last night, Standard BioTools Inc’s stock clocked out at $2.63, down -1.87% from its previous closing price of $2.68. In other words, the price has decreased by -$0.0500 from its previous closing price. On the day, 3351979 shares were traded.
Ratios:
To gain a deeper understanding of LAB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.26 and its Current Ratio is at 1.45. In the meantime, Its Debt-to-Equity ratio is 0.60 whereas as Long-Term Debt/Eq ratio is at 0.21.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, KeyBanc Capital Markets on July 12, 2023, initiated with a Overweight rating and assigned the stock a target price of $4.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 05 ’24 when Casdin Partners Master Fund, L bought 1,403 shares for $2.62 per share. The transaction valued at 3,669 led to the insider holds 11,497,928 shares of the business.
Casdin Partners Master Fund, L bought 250,000 shares of LAB for $642,500 on Mar 04 ’24. The Director now owns 11,496,525 shares after completing the transaction at $2.57 per share. On May 19 ’23, another insider, Casdin Partners Master Fund, L, who serves as the Director of the company, bought 800,000 shares for $2.29 each. As a result, the insider paid 1,835,920 and bolstered with 1,200,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LAB now has a Market Capitalization of 767.36M and an Enterprise Value of 750.68M. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.18. Its current Enterprise Value per Revenue stands at 7.06 whereas that against EBITDA is -13.78.
Stock Price History:
Over the past 52 weeks, LAB has reached a high of $3.16, while it has fallen to a 52-week low of $1.46. The 50-Day Moving Average of the stock is 2.3638, while the 200-Day Moving Average is calculated to be 2.3482.
Shares Statistics:
It appears that LAB traded 1.73M shares on average per day over the past three months and 2.37M shares per day over the past ten days. A total of 290.12M shares are outstanding, with a floating share count of 280.45M. Insiders hold about 3.33% of the company’s shares, while institutions hold 31.68% stake in the company. Shares short for LAB as of Feb 29, 2024 were 7.92M with a Short Ratio of 4.57, compared to 7.3M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.73% and a Short% of Float of 2.91%.
Earnings Estimates
As of right now, 1 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was $0. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.01 and -$0.01 for the fiscal current year, implying an average EPS of -$0.01. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
